Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
11 Septiembre 2023 - 7:00AM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an
industry leader in exoskeleton technology for medical and
industrial use, today announced that Scott Davis, Chief Executive
Officer, and Jerome Wong, Chief Financial Officer, will be
participating in a fireside chat at the H.C. Wainwright 25th Annual
Global Investment Conference taking place in New York on September
11-13, 2023.
The fireside chat will begin at 1:00 PM PT /
4:00 PM ET on Wednesday, September 13, 2023. A live webcast of the
fireside chat will be available on the Investors section of the
Company’s website at www.eksobionics.com or by clicking here. A
replay will be available on the Company’s website following the
event.
In connection with Ekso’s participation at the
H.C. Wainwright conference, a new investor presentation has been
posted to the Company’s website. The presentation, which highlights
the Company’s mission, investment value proposition, growth
strategy and financials, can be found on Ekso’s investor relations
website under Presentations and Events.
Management will also be participating in
one-on-one meetings with institutional investors throughout the
conference. For those interested in a meeting, please contact your
H.C. Wainwright representative.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance, and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only known exoskeleton company
to offer technologies that range from helping those with paralysis
to stand up and walk, to enhancing human capabilities on job sites
across the globe. Ekso Bionics is headquartered in the San
Francisco Bay Area and is listed on the Nasdaq Capital Market under
the symbol “EKSO.” For more information, visit: www.eksobionics.com
or follow @EksoBionics on Twitter.
Investor Contact:David
Carey212-867-1768investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Ekso Bionics (NASDAQ:EKSO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024